4.8 Article

Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution

期刊

NUCLEIC ACIDS RESEARCH
卷 36, 期 13, 页码 4510-4520

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkn419

关键词

-

资金

  1. NHLBI NIH HHS [R01 HL070925] Funding Source: Medline
  2. NIA NIH HHS [P01 AG021830] Funding Source: Medline
  3. NIEHS NIH HHS [P30 ES06676, P30 ES006676] Funding Source: Medline

向作者/读者索取更多资源

Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor that plays a crucial role in interleukin-6 (IL-6) signaling, mediating the acute-phase induction of the human Angiotensinogen (hAGT) gene in hepatocytes. We showed earlier that IL-6 induces acetylation of the STAT3 NH2-terminus by the recruitment of the p300 coactivator. We had also observed a physical interaction of STAT3 and Histone Deacetylase1 (HDAC1) in an IL-6-dependent manner that leads to transcriptional repression. In this study, we sought to elucidate the mechanism by which HDAC1 controls STAT3 transcriptional activity. Here, we mapped the interacting domains of both STAT3 and HDAC1 and found that the COOH-terminal domain of HDAC1 is necessary for IL-6-induced STAT3 transcriptional repression, whereas the NH2-terminal acetylation domain of STAT3 is required for HDAC1 binding. Interestingly, over expression of HDAC1 in HepG2 cells leads to significantly reduced amounts of nuclear STAT3 after IL-6 induction, whereas silencing of HDAC1 resulted in accumulation of total and acetylated STAT3 in the nucleus. We have found that HDAC1 knockdown also interferes with the responsiveness of the STAT3-dependent MCP1 target gene expression to IL-6, as confirmed by real-time RTPCR analysis. Together, our study reveals the novel functional consequences of IL-6-induced STAT3-HDAC1 interaction on nucleocytoplasmic distribution of STAT3.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma

Matthew J. Kling, Connor N. Griggs, Erin M. McIntyre, Gracey Alexander, Sutapa Ray, Kishore B. Challagundla, Shantaram S. Joshi, Don W. Coulter, Nagendra K. Chaturvedi

Summary: The study demonstrated the potential therapeutic efficacy of targeting dysregulated protein synthesis pathways by inhibiting MYCN and mTOR signaling simultaneously in NB, particularly showing significant effects on MYCN-amplified NB cells. Further preclinical evaluation is needed to assess the clinical utility of this targeted therapy for high-risk NB patients.

BMC CANCER (2021)

Article Oncology

Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation

Heyu Song, Shaoyan Xi, Yingling Chen, Suravi Pramanik, Jiping Zeng, Shrabasti Roychoudhury, Hannah Harris, Anum Akbar, Salma S. Elhag, Donald W. Coulter, Sutapa Ray, Kishor K. Bhakat

Summary: MB tumors exhibit elevated levels of the nucleosome remodeling FACT complex and DNA repair enzyme APE1, which promote repair of DNA damage induced by radiation and cisplatin. Targeting the FACT complex with CBL0137 enhances the potency of cisplatin and radiation, leading to the suppression of MB tumor growth.

CANCER LETTERS (2021)

Article Genetics & Heredity

The FAcilitates Chromatin Transcription (FACT) complex: Its roles in DNA repair and implications for cancer therapy

Kishor K. Bhakat, Sutapa Ray

Summary: Genomic DNA in the nucleus is wrapped around nucleosomes, consisting of core histones. The histone chaperone complex FACT is involved in nucleosome remodeling during processes like transcription and DNA repair, playing a crucial role in various repair pathways. Overexpression of FACT in cancer is associated with drug resistance and poor prognosis, while inhibitors like curaxins show promise in sensitizing cancer to chemotherapy and radiation.

DNA REPAIR (2022)

Article Gastroenterology & Hepatology

Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases

Yi Li, Jianping Chen, Andrew A. Bolinger, Haiying Chen, Zhiqing Liu, Yingzi Cong, Allan R. Brasier, Irina Pinchuk, Bing Tian, Jia Zhou

Summary: Inflammatory bowel disease (IBD) is a serious chronic gastrointestinal disease, with long-term inflammation contributing to neoplastic transformation and colorectal cancer development. The discovery of new small molecule drugs targeting specific pathways in mucosal inflammation offers hope for the treatment of IBD.

INFLAMMATORY BOWEL DISEASES (2021)

Review Medicine, General & Internal

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment

Sutapa Ray, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino, Sidharth Mahapatra

Summary: Medulloblastoma is the most common malignant central nervous system tumor in pediatric patients. Tumors can be divided into average and high-risk status based on age, metastasis at diagnosis, and extent of surgical resection. High-throughput screening has allowed for the identification of four primary subgroups, each with further subdivisions based on cytogenetic and epigenetic events. Exploiting these genetic aberrations may lead to novel targeted therapeutics.

DIAGNOSTICS (2022)

Article Biochemistry & Molecular Biology

The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells

Suravi Pramanik, Yingling Chen, Heyu Song, Irine Khutsishvili, Luis A. Marky, Sutapa Ray, Amarnath Natarajan, Pankaj K. Singh, Kishor K. Bhakat

Summary: This study identifies a novel role for the protein APE1 in regulating stable G4 formation and KRAS expression in PDAC, suggesting that G4 structures could be potential prognostic markers and therapeutic targets for PDAC.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemical Research Methods

Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling

Yanlong Zhu, Stephane Esnault, Ying Ge, Nizar N. Jarjour, Allan R. Brasier

Summary: Airway remodeling in patients with asthma is associated with leukocyte numbers and remodeling markers. Patients with lower FEV1 have distinct dynamic responses to allergens.

CLINICAL PROTEOMICS (2022)

Article Biochemistry & Molecular Biology

Segmental Bronchial Allergen Challenge Elicits Distinct Metabolic Phenotypes in Allergic Asthma

Yanlong Zhu, Stephane Esnault, Ying Ge, Nizar N. Jarjour, Allan R. Brasier

Summary: This study analyzed metabolites in bronchoalveolar fluid (BALF) during a bronchial antigen challenge and identified distinct metabolic responses, providing insight into pathogenic and protective subtypes in allergic asthma.

METABOLITES (2022)

Article Biochemistry & Molecular Biology

Genomic targets of the IRE1-XBP1s pathway in mediating metabolic adaptation in epithelial plasticity

Dianhua Qiao, Melissa Skibba, Xiaofang Xu, Allan R. Brasier

Summary: Epithelial mesenchymal plasticity (EMP) is a complex cellular reprogramming event that plays a major role in tissue homeostasis. Recently, the unfolded protein response (UPR) was found to trigger EMP through the IRE1 alpha-XBP1s axis, enhancing glucose shunting to protein N glycosylation. By identifying the genomic targets of XBP1s using CUT&RUN, it was discovered that XBP1s peaks were located near various promoters of genes controlling Rho-GTPase signaling, N-linked glycosylation, and ER-Golgi transport. Moreover, the IRE1 alpha-XBP1s pathway was shown to regulate mesenchymal transcription factors and hexosamine biosynthesis in EMP by recruiting activated RNA Pol II to GC-rich promoters.

NUCLEIC ACIDS RESEARCH (2023)

Editorial Material Medicine, Research & Experimental

Orchestrating epigenetic readers: Progress in understanding the functions of bromodomain- containing protein 4 complexes

Allan R. Brasier

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Article Oncology

STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo

Kyle A. Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino, Don W. Coulter, Sutapa Ray

Summary: Medulloblastoma (MB) is a common childhood malignant brain tumor that accounts for a significant percentage of pediatric central nervous system tumors. This study reveals the functional role of activated STAT3 in promoting MB tumorigenesis and chemoresistance by inducing the oncogene MYC. Inhibiting STAT3 can reduce the growth and survival of MB cells and improve treatment efficacy, especially in high-risk MYC-amplified tumors.

CANCERS (2023)

Review Medicine, Research & Experimental

A leadership model supporting maturation of high-performance translational teams

Allan. R. R. Brasier, Shannon. L. L. Casey, Peggy Hatfield, Patrick. W. W. Kelly, Whitney. A. A. Sweeney, Marin Schweizer, Bo Liu, Elizabeth. S. S. Burnside

Summary: This study proposes a model for developing leadership in translational teams (TTs) from team formation to dissemination and implementation. It identifies the stable impact of leadership behaviors on team development and emphasizes the importance of ongoing reflection, evaluation, and practice to enhance leadership skills. The study also provides a comprehensive multi-level evaluation framework to track the growth of TT leadership skills.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Review Medicine, Research & Experimental

Temporal development of high-performance translational teams

Allan R. Brasier, Shannon L. Casey, Felice Resnik, Betsy Rolland, Elizabeth S. Burnside

Summary: Successful translation involves the application of research and product development to advance healthcare interventions. Training in team skills and attitudes can enhance translational team performance. Interdisciplinary teams undergo developmental phases, with each phase promoting knowledge generation and translation. Antecedents of stage-dependent competencies and assessment rubrics can guide training interventions for improving performance in the clinical context.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Review Medicine, Research & Experimental

Competencies supporting high-performance translational teams: A review of the SciTS evidence base

Allan R. Brasier, Elizabeth S. Burnside, Betsy Rolland

Summary: A translational team is a type of interdisciplinary team that aims to improve human health. Understanding how to promote team performance in the areas of affect, communication, management, collaborative problem-solving, and leadership is essential. This study conducted a literature review to identify key competencies that enhance team performance and develop strategies for training interventions.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

暂无数据